INVO Fertility Return on Tangible Equity 2010-2025 | IVF
Current and historical return on tangible equity values for INVO Fertility (IVF) over the last 10 years. Return on tangible equity can be defined as the amount of net income returned as a percentage of shareholders equity, after subtracting intangible assets, goodwill and preferred equity.
| INVO Fertility Return On Tangible Equity Historical Data | |||
|---|---|---|---|
| Date | TTM Net Income | Tangible Equity | Return on Tangible Equity |
| 2025-03-31 | $-0.03B | $-0.02B | 175.44% |
| 2024-12-31 | $-0.01B | $-0.02B | 83.33% |
| 2024-09-30 | $-0.01B | $-0.01B | 88.89% |
| 2024-06-30 | $-0.01B | $-0.01B | 75.68% |
| 2024-03-31 | $-0.01B | $-0.01B | 90.32% |
| 2023-12-31 | $-0.01B | $-0.01B | 152.38% |
| 2023-09-30 | $-0.01B | $-0.01B | 276.92% |
| 2023-06-30 | $-0.01B | $0.00B | 2200.00% |
| 2023-03-31 | $-0.01B | $0.00B | -1600.00% |
| 2022-12-31 | $-0.01B | $0.00B | -600.00% |
| 2022-09-30 | $-0.01B | $0.00B | -225.00% |
| 2022-06-30 | $-0.01B | $0.00B | -188.24% |
| 2022-03-31 | $-0.01B | $0.01B | -155.56% |
| 2021-12-31 | $-0.01B | $0.01B | -133.33% |
| 2021-09-30 | $-0.01B | $0.00B | -235.29% |
| 2021-06-30 | $-0.01B | $0.00B | -363.64% |
| 2021-03-31 | $-0.01B | $0.01B | -1200.00% |
| 2020-12-31 | $-0.01B | $0.01B | 533.33% |
| 2020-09-30 | $-0.01B | $0.00B | 125.00% |
| 2020-06-30 | $0.00B | $0.00B | 100.00% |
| 2020-03-31 | $0.00B | $0.00B | 80.00% |
| 2019-12-31 | $0.00B | $0.00B | 57.14% |
| 2019-09-30 | $0.00B | $0.00B | 61.54% |
| 2019-06-30 | $0.00B | $0.00B | 30.77% |
| 2019-03-31 | $0.00B | $0.00B | 85.71% |
| 2018-12-31 | $0.00B | $0.00B | 75.00% |
| 2018-09-30 | $0.00B | $0.00B | 44.44% |
| 2018-06-30 | $0.00B | $0.00B | 42.11% |
| 2018-03-31 | $0.00B | $-0.01B | 0.00% |
| 2017-12-31 | $0.00B | $-0.01B | 0.00% |
| 2017-09-30 | $0.00B | $-0.01B | 0.00% |
| 2017-06-30 | $0.00B | $-0.01B | 0.00% |
| 2017-03-31 | $0.00B | $-0.01B | 22.22% |
| 2016-12-31 | $0.00B | $-0.01B | 23.53% |
| 2016-09-30 | $0.00B | $0.00B | 25.00% |
| 2016-06-30 | $0.00B | $0.00B | 33.33% |
| 2016-03-31 | $0.00B | $0.00B | 200.00% |
| 2015-12-31 | $0.00B | $0.00B | 400.00% |
| 2015-09-30 | $0.00B | 533.33% | |
| 2015-06-30 | $0.00B | 266.67% | |
| 2015-03-31 | $0.00B | 0.00% | |
| 2011-12-31 | $0.00B | $0.00B | 0.00% |
| 2011-09-30 | $0.00B | $0.00B | 0.00% |
| 2011-06-30 | $0.00B | $0.00B | 0.00% |
| 2011-03-31 | $0.00B | $0.00B | 0.00% |
| 2010-12-31 | $0.00B | $0.00B | -44.44% |
| 2010-09-30 | $0.00B | $0.00B | -44.44% |
| 2010-06-30 | $0.00B | $0.00B | 66.67% |
| 2010-03-31 | $0.00B | $0.00B | 66.67% |
| 2009-12-31 | $0.00B | $0.00B | 145.45% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $0.003B | $0.007B |
| INVO Fertility Inc. is a healthcare services fertility company focused on expanding access to advanced treatment through the establishment, acquisition and operation of fertility clinics. INVO Fertility Inc., formerly known as NAYA Biosciences Inc., is based in SARASOTA, Fla. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Danaher (DHR) | United States | $139.155B | 26.10 |
| Elevance Health (ELV) | United States | $84.931B | 10.96 |
| CVS Health (CVS) | United States | $84.554B | 10.51 |
| Cencora (COR) | United States | $57.517B | 20.01 |
| Natera (NTRA) | United States | $23.347B | 0.00 |
| DiDi Global (DIDIY) | China | $22.403B | 23.80 |
| Labcorp Holdings (LH) | United States | $21.878B | 17.75 |
| BioMerieux (BMXMF) | France | $16.861B | 0.00 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $13.676B | 0.00 |
| Solventum (SOLV) | United States | $12.566B | 13.30 |
| CochLear (CHEOY) | Australia | $12.083B | 0.00 |
| ICON (ICLR) | Ireland | $11.595B | 10.78 |
| Revvity (RVTY) | United States | $11.128B | 19.15 |
| Doximity (DOCS) | United States | $10.714B | 49.60 |
| Viatris (VTRS) | United States | $10.293B | 3.54 |
| Avantor (AVTR) | United States | $9.056B | 13.16 |
| HealthEquity (HQY) | United States | $8.820B | 38.64 |
| Medpace Holdings (MEDP) | United States | $8.700B | 23.11 |
| Sonic Healthcare (SKHHY) | Australia | $8.407B | 0.00 |
| Charles River Laboratories (CRL) | United States | $7.136B | 13.98 |
| Amplifon S.p.A (AMFPF) | Italy | $5.378B | 29.44 |
| Bausch + Lomb (BLCO) | Canada | $4.085B | 24.06 |
| BrightSpring Health Services (BTSG) | United States | $3.934B | 36.10 |
| Sotera Health (SHC) | United States | $3.105B | 17.65 |
| Alignment Healthcare (ALHC) | United States | $2.849B | 0.00 |
| Concentras Parent (CON) | United States | $2.676B | 15.47 |
| Organon (OGN) | United States | $2.568B | 2.73 |
| Surgery Partners (SGRY) | United States | $2.542B | 33.06 |
| PACS (PACS) | United States | $2.027B | 0.00 |
| Progyny (PGNY) | United States | $1.856B | 40.85 |
| Ardent Health (ARDT) | United States | $1.854B | 7.90 |
| GeneDx Holdings (WGS) | United States | $1.838B | 70.80 |
| Premier (PINC) | United States | $1.834B | 13.92 |
| GoodRx Holdings (GDRX) | United States | $1.600B | 32.00 |
| Teladoc Health (TDOC) | United States | $1.230B | 0.00 |
| Pediatrix Medical (MD) | United States | $1.147B | 8.73 |
| Establishment Labs Holdings (ESTA) | $1.100B | 0.00 | |
| CareDx (CDNA) | United States | $1.060B | 16.55 |
| Ryman Healthcare (RYHTY) | New Zealand | $1.011B | 0.00 |
| Agilon Health (AGL) | United States | $0.902B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $0.856B | 8.01 |
| QDM (QDMI) | Hong Kong, SAR China | $0.758B | 0.00 |
| LifeMD (LFMD) | United States | $0.684B | 0.00 |
| Nutex Health (NUTX) | United States | $0.661B | 10.01 |
| Embecta (EMBC) | United States | $0.569B | 3.83 |
| InnovAge Holding (INNV) | United States | $0.512B | 0.00 |
| SBC Medicals (SBC) | United States | $0.482B | 0.00 |
| Enhabit (EHAB) | United States | $0.473B | 38.92 |
| Auna S.A (AUNA) | Luxembourg | $0.459B | 10.33 |
| Sonida Senior Living (SNDA) | United States | $0.454B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.449B | 0.00 |
| Omada Health (OMDA) | $0.399B | 0.00 | |
| Performant Healthcare (PHLT) | United States | $0.267B | 0.00 |
| Oncology Institute (TOI) | United States | $0.212B | 0.00 |
| Beauty Health (SKIN) | United States | $0.184B | 0.00 |
| DocGo (DCGO) | United States | $0.165B | 27.00 |
| Pheton Holdings (PTHL) | China | $0.119B | 0.00 |
| So-Young (SY) | China | $0.102B | 0.00 |
| KindlyMD (NAKA) | United States | $0.084B | 0.00 |
| Sera Prognostics (SERA) | United States | $0.071B | 0.00 |
| NeueHealth (NEUE) | United States | $0.061B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.059B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| ModivCare (MODV) | United States | $0.052B | 0.00 |
| Basel Medical Group (BMGL) | Singapore | $0.049B | 0.00 |
| Biodesix (BDSX) | United States | $0.040B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.034B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.013B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.011B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.009B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.005B | 0.00 | |
| XWELL (XWEL) | United States | $0.005B | 0.00 |
| Aclarion (ACON) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.002B | 0.00 |
| NewGenIvf Group (NIVF) | Thailand | $0.001B | 0.00 |
| Cano Health (CANOQ) | United States | $0.000B | 0.00 |